Related Experiment Video
Updated: Dec 16, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
The molecular genetic basis of atrial fibrillation
Xin Huang1, Yuhui Li2, Junguo Zhang1
1Center for Clinical Epidemiology and Methodology (CCEM), Guangdong Second Provincial General Hospital, 466 Newport Middle Road, Haizhu District, Guangzhou, 510317, Guangdong, China.
Insights
Atrial fibrillation (AF) has a strong genetic basis. Understanding AF genetics is key to developing better treatments for this common heart rhythm disorder.
Area of Science:
- Cardiovascular Genetics
- Molecular Epidemiology
Background:
- Atrial fibrillation (AF) is the most common cardiac arrhythmia, posing significant risks for stroke, heart failure, and mortality.
- Current treatments for AF lack optimal benefit-harm profiles due to incomplete understanding of its underlying biological mechanisms.
- Molecular epidemiological studies, particularly genome-wide association studies (GWAS), highlight a substantial genetic contribution to AF etiology.
Purpose of the Study:
- To provide a comprehensive review of the molecular genetics of atrial fibrillation.
- To explore the genetic underpinnings of AF to advance the understanding of its mechanisms.
- To facilitate the identification of novel therapeutic targets for AF.
Main Methods:
- Review of evidence from linkage analysis and candidate gene studies.
- Analysis of genome-wide association studies (GWAS) for common variations.
- Inclusion of studies on rare copy number variations and epigenetic modifications (DNA methylation, histone modification, non-coding RNAs).
Main Results:
- Significant genetic factors contribute to the etiology of atrial fibrillation.
- Evidence spans various genetic approaches, including traditional and genome-wide studies.
- Epigenetic modifications also play a role in AF pathogenesis.
Conclusions:
- A comprehensive understanding of AF's genetic architecture is crucial for mechanistic insights.
- Further research into genetic and epigenetic factors is essential for developing improved AF therapies.
- Addressing challenges in mechanism investigation will pave the way for future therapeutic advancements.
Abstract:
As the most common cardiac arrhythmia, atrial fibrillation (AF) is a major risk factor for stroke, heart failure, and premature death with considerable associated costs. However, no available treatment options have optimal benefit-harm profiles currently, reflecting an incomplete understanding of the biological mechanisms underlying this complex arrhythmia. Recently, molecular epidemiological studies, especially genome-wide association studies, have emphasized the substantial genetic component of AF etiology. A comprehensive mapping of the genetic underpinnings for AF can expand our knowledge of AF mechanism and further facilitate the process of locating novel therapeutics for AF. Here we provide a state-of-the-art review of the molecular genetics of AF incorporating evidence from linkage analysis and candidate gene, as well as genome-wide association studies of common variations and rare copy number variations; potential epigenetic modifications (e.g., DNA methylation, histone modification, and non-coding RNAs) are also involved. We also outline the challenges in mechanism investigation and potential future directions in this article.
Related Concept Videos
Mechanism of Cardiac Arrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Anticoagulant Drugs: Low-Molecular-Weight Heparins

